A Challenging Case Of Ventricular Arrhythmia In A Patient With Myocarditis: ICD Yes/No After Ablation

Area of Science:

• Cardiology
• Cardiac Electrophysiology
• Cardiovascular Imaging

Background:

• Myocarditis requires prompt diagnosis and therapy, with close monitoring for disease progression and ventricular arrhythmias.
• Current management of ventricular arrhythmias in myocarditis follows implantable cardioverter-defibrillator (ICD) guidelines, but novel therapeutic strategies are being explored.

Observation:

• Depressed left ventricular ejection fraction (LVEF) is the sole established risk marker for sudden cardiac death (SCD) in myocarditis, yet its predictive utility is limited.
• Emerging therapeutic options include combined epicardial/endocardial ablation and external wearable defibrillators for managing ventricular arrhythmias.

Findings:

• A combined analysis of myocardial tissue structure via cardiac magnetic resonance (CMR) and endomyocardial biopsy, alongside resting cardiac systolic function, may enhance SCD predictive accuracy.
• Integrating advanced imaging and biopsy data offers a more comprehensive risk assessment than LVEF alone.

Implications:

• Improved risk stratification for SCD in myocarditis patients can guide personalized treatment strategies.
• The findings support the development of more accurate predictive models for sudden cardiac death in myocarditis.
• Further research into combined diagnostic approaches could refine clinical management and improve patient outcomes.